Zacks Industry Outlook Highlights Sprout and HealthStream
Zacks Equity Research highlights Sprout Social, Inc. and HealthStream, Inc. as strong performers in the Internet Services industry, driven by global digitization and AI adoption. Both companies are leveraging technology and industry expertise for growth, with Sprout Social focusing on larger enterprises and HealthStream benefiting from demand for healthcare workforce solutions. Despite macroeconomic headwinds and competitive pressures, both stocks show strong earning estimate revisions and appear fairly valued.
Buy Internet Service Players Sprout Social and HealthStream
The Internet Services industry is poised for continued growth due to global digitization, with AI adoption being a significant driver. Sprout Social (SPT) and HealthStream (HSTM) are highlighted as strong investment opportunities, leveraging innovative technology and AI to enhance their offerings and deepen customer relationships. Both companies operate in attractive markets, despite facing macroeconomic headwinds and increasing competitive pressures.
Have Insiders Sold HealthStream Shares Recently?
HealthStream (NASDAQ:HSTM) recently saw its CFO and Senior VP of Accounting & Finance, Scott Roberts, divest US$306k worth of shares, representing a 25% reduction in his holding. This follows a larger sale by Co-Founder Robert Frist in the last twelve months. While insider selling occurred, no insider purchases were reported, though the company is noted as profitable and growing with significant insider ownership.
HealthStream, Inc. (HSTM) stock price, news, quote and history
HealthStream, Inc. (HSTM) stock closed at $28.29, down 2.04%, but was up 0.07% in after-hours trading. The company announced a cash dividend of $0.035 with an ex-date of November 16, 2026. HealthStream provides SaaS-based applications for healthcare organizations, including platforms for provider lifecycle management, clinical competency development, and scheduling.
HealthStream, Inc. (HSTM) Seasonal Returns Chart - Yahoo Finance
The Yahoo Finance article provides a seasonal returns chart for HealthStream, Inc. (HSTM), detailing average monthly price returns from 2016-2026. It also notes HSTM's current stock price, recent performance, and a declared cash dividend of $0.035 with an ex-date of November 16, 2026.
Form 4 HealthStream Inc: Tate Deborah Taylor (Director) For: 6 November
This article reports on a Form 4 filing for HealthStream Inc, specifically detailing an insider transaction by Director Tate Deborah Taylor for November 6th. The filing indicates a change in ownership which is a standard disclosure for company insiders. The stock symbol for HealthStream Inc is HSTM.
HealthStream (NASDAQ:HSTM) Downgraded by Wall Street Zen to "Hold"
HealthStream (NASDAQ:HSTM) has been downgraded by Wall Street Zen from "Buy" to "Hold," reflecting a cautious sentiment also echoed by other analysts and a consensus price target of $36.00. Despite beating quarterly earnings and revenue estimates, the company has seen significant insider share sales, totaling approximately $5.8 million over the past 90 days. Institutional investors have shown mixed activity, with some acquiring new positions while others increased their stakes.
Insider Selling: HealthStream (NASDAQ:HSTM) CFO Sells 9,500 Shares of Stock
HealthStream's CFO, Scott Alexander Roberts, sold 9,500 shares of company stock for $306,470, reducing his direct ownership by nearly 25%. This transaction occurred shortly after HealthStream (NASDAQ:HSTM) reported quarterly earnings that surpassed analyst expectations. Despite the insider selling, institutional investors have increased their holdings in the company, and analysts generally hold a "Hold" rating on the stock with an average price target of $36.00.
HealthStream (NASDAQ:HSTM) EVP Sells 21,300 Shares of Stock
HealthStream EVP Michael Manning Collier sold 21,300 shares of the company's stock for approximately $638,361, reducing his direct stake by over 26%. This transaction follows HealthStream's recent financial results, where it surpassed quarterly earnings and revenue estimates and declared a quarterly dividend. Analysts currently have a "Hold" consensus rating for HealthStream with an average price target of $36.00.
Healthstream Executive Vice President Sold Shares Worth Over $638K
Collier Michael Manning, Executive Vice President of Healthstream, sold 21,300 shares of common stock on November 5, 2026, across two transactions. The sales, at weighted average prices of $30.5972 and $29.8535 per share, totaled approximately $638,333. Following these transactions, Manning directly holds 59,260 shares.
After selling 9,500 shares, HealthStream (HSTM) CFO holds 29,160 shares directly.
HealthStream, Inc. (HSTM) CFO and SVP Scott Alexander Roberts sold 9,500 shares of common stock on November 5, 2026, at a weighted average price of $32.2615 per share. Following this transaction, Roberts directly holds 29,160 shares. The sale was executed in multiple trades with prices ranging from $32.00 to $32.95.
Director Deborah Taylor Tate proposes selling 3,281 HealthStream (HSTM) shares worth $106K.
HealthStream, Inc. director Deborah Taylor Tate has proposed selling 3,281 shares of common stock, valued at $106,000, through Raymond James & Associates, Inc., with an approximate sale date of November 5, 2026. The sale includes shares acquired as restricted share units in March and June of 2025. This information was reported via a Form 144 SEC filing.
HealthStream, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
HealthStream, Inc. (NASDAQ:HSTM) recently released its quarterly results, with revenues largely meeting expectations and statutory earnings per share (EPS) beating analyst predictions by 14%. Despite the positive EPS surprise, analysts have not significantly changed their forecasts for 2027, maintaining revenue estimates at US$345.5m and slightly adjusting EPS to US$0.82. The consensus price target remains steady at US$35.00, indicating that the recent results did not alter the overall outlook for the company's future performance relative to expectations.
HealthStream downgraded by Craig Hallum with a new price target
Craig Hallum downgraded HealthStream (HSTM) from Buy to Hold, setting a new price target of $40.00. Quantisnow alerted its Plus members about this analyst rating change immediately after publication. The article also provides historical stock performance data for HSTM following previous headlines and details about its market data and recent insider transactions.
HealthStream, Inc. (NASDAQ:HSTM) Stock Has Consensus Target Price of $33.50
HealthStream, Inc. (NASDAQ:HSTM) has a consensus "Hold" rating from analysts, with an average 12-month price target of $33.50. The company recently surpassed quarterly revenue and EPS estimates, and management issued optimistic fiscal 2026 revenue guidance. While institutional investors hold a significant stake, the CEO and a director reduced their holdings, and the company declared a quarterly dividend of $0.035 per share.
Craig-Hallum Downgrades HealthStream to Hold After 39% Year-to-Date Gain
Craig-Hallum downgraded HealthStream, Inc. (HSTM) to "hold" from "buy" on November 3rd, citing the stock's significant rally. Shares had gained 39% year-to-date and 50% over the last six months, pushing its valuation too high despite good quarterly results. The firm pointed to these gains as the primary reason for the rating change.
HealthStream (HSTM) Stock Drops After Q3 Earnings Margin Squeeze
HealthStream (HSTM) stock fell 8.4% after its Q3 2026 earnings report, despite revenue growth. The market reacted negatively to a squeeze on earnings and margins, with net income and basic EPS declining year-over-year. While the company is making progress in shifting towards SaaS platforms and bundled suites, the cost of this transition is impacting profitability.
HealthStream Releases Q3 2026 Financial Results
HealthStream, Inc. (HSTM) reported strong third-quarter 2026 financial results, exceeding analyst expectations with an adjusted EPS of $0.18 against estimates of $0.16. The company posted net income of $5.4 million and revenue of $83.3 million, an 8.9% increase from Q3 2025. Management also issued full-year revenue guidance of $331.0 million to $333.0 million, reflecting continued demand for its healthcare workforce solutions.
What HealthStream (HSTM) Said on Its Q3 Earnings Call
HealthStream (HSTM) reported an 8.9% increase in Q3 2026 revenue, reaching $83.3 million, and subsequently raised its full-year guidance. The company highlighted strong subscription growth, a shift towards integrated suite offerings, and strategic investments in its technology platform and cloud migration. Despite some near-term margin pressure from cloud consolidation and higher labor costs, management anticipates long-term benefits in efficiency and security.
Earnings call transcript: HealthStream tops Q3 2026 estimates, raises outlook again
HealthStream (HSTM) surpassed Q3 2026 adjusted earnings and revenue estimates, reporting $0.18 per share on $83.3 million in revenue against expectations of $0.16 per share on $82.24 million. The company raised its full-year 2026 guidance for the second consecutive quarter, projecting revenue between $331 million and $333 million. While profit declined year-over-year due to increased operating expenses and cloud migration costs, HealthStream emphasized its shift towards integrated programmatic suites and a strong balance sheet to support future investments and acquisitions.
HealthStream Q3 2026 Earnings Call Is Live
HealthStream's Q3 2026 earnings call has commenced, where executives will discuss the latest financial results and answer questions from Wall Street analysts. This event is critical for investors following HSTM, as management commentary can significantly influence market sentiment, especially regarding future outlooks, margins, and capital expenditures.
HealthStream earnings beat by $0.02, revenue topped estimates
HealthStream (NASDAQ: HSTM) reported third-quarter EPS of $0.18, exceeding analyst estimates by $0.02. The company's revenue for the quarter was $83.3 million, also surpassing the consensus estimate of $82.24 million. HealthStream's stock has seen significant growth, up 22.97% in the last 3 months and 36.57% in the last 12 months.
Form 8K HealthStream Inc For: 2 November By Investing.com
HealthStream Inc. (HSTM) has filed a Form 8K report on November 2, 2026. This filing, made public by Investing.com, indicates a significant event or disclosure relevant to the company's investors. The article provides the title of the filing and its publication date without further details on the content of the 8K.
HealthStream Announces Third Quarter 2026 Results
HealthStream, Inc. announced its third quarter 2026 financial results, with revenues increasing 8.9% to $83.3 million compared to the same period in 2025. Despite a rise in operating expenses due to investments and a cybersecurity incident, the company reported a net income of $5.4 million and an adjusted EBITDA of $19.3 million. HealthStream also updated its full-year 2026 guidance, reflecting increased expectations for revenue, net income, and adjusted EBITDA.
HealthStream (HSTM) Rallied On Resilient Subscription Revenue But Is The Valuation Already Priced In
HealthStream (HSTM) has seen strong share price performance recently but experienced a slight pullback. Analysts are divided, with one narrative suggesting the stock is 16% undervalued at a fair value of $40.00 due to its subscription revenue, strong balance sheet, and investments in new platforms. However, another perspective highlights valuation risks, noting its P/E ratio of 48.6x is significantly higher than the industry average.
HealthStream, Inc. (HSTM) Seasonal returns chart
The article provides a seasonal returns chart for HealthStream, Inc. (HSTM), showing its average monthly price return from 2016 to 2026. As of the time of publication, HSTM stock was trading at 34.05 USD, up 1.04%. The company's Q3 2026 earnings call is scheduled for November 3, 2026.
218 shares were withheld for taxes after an EVP’s stock award vested at HealthStream (HSTM).
HealthStream Inc. Executive Vice President Kevin P. O’Hara reported the vesting of 895 restricted share units (RSUs) on October 29, 2026, leading to the acquisition of 895 common shares. For tax liability, 218 common shares were withheld at a price of $34.18 per share. Following this transaction, O'Hara's RSU position became zero, and his direct common stock holdings totaled 22,901 shares.
Form 4 HealthStream Inc: Jeff Cunningham (CTO) For: 29 October By Investing.com
This article from Investing.com reports on a Form 4 filing for HealthStream Inc, specifically concerning Chief Technology Officer Jeff Cunningham, for transactions that occurred on October 29. The brief notice provides the company's stock symbol (HSTM) and indicates a slight negative change in its stock price. It also states the article was published on October 30, 2026, at 00:32 UTC.
Stock award vesting brings HealthStream (HSTM) CTO 895 shares; 218 are withheld for taxes.
HealthStream (HSTM) Chief Technology Officer Jeff Cunningham acquired 895 shares of common stock on October 29, 2026, due to the vesting of restricted share units. Concurrently, 218 shares were withheld for tax liability at $34.18 per share. The RSUs were part of a four-year vesting schedule, with the final 35% vesting on October 27, 2026.
218 shares withheld for taxes as HealthStream (HSTM) CFO's 895-share award vests.
HealthStream Inc.'s CFO and SVP, Scott Alexander Roberts, acquired 895 common shares as restricted share units vested on October 29, 2026. Concurrently, 218 shares were withheld to cover tax liabilities, valued at $34.18 per share. This transaction follows a four-year vesting schedule for the RSUs.
Form 4 HealthStream Inc: Michael Manning Collier (Executive Vice President) For: 29 October By Investing.com
This article reports on a Form 4 filing for HealthStream Inc, indicating an insider transaction by Michael Manning Collier, Executive Vice President. The filing pertains to activity on October 29. The document provides no further details on the nature of the transaction.
HealthStream CFO Scott Roberts Vests 895 RSUs and Withholds 218 Shares for Taxes on October 29, 2026
HealthStream Inc.'s CFO and SVP, Scott Alexander Roberts, reported the vesting of 895 restricted share units (RSUs) on October 29, 2026. Simultaneously, 218 shares were withheld at a price of $34.18 each to cover tax obligations. Following these transactions, Roberts directly owns 38,660 shares of HealthStream common stock.
An SVP acquires 895 HealthStream (HSTM) shares; 218 shares are withheld for taxes.
HealthStream Inc. (HSTM) Senior Vice President Michael Scott McQuigg acquired 895 common shares on October 29, 2026, when 895 restricted share units vested. Concurrently, 218 common shares were withheld for tax liability at $34.18 per share. The restricted share units were subject to a four-year vesting schedule tied to continued service.
Citizens reiterates HealthStream stock rating ahead of Q3 results
Citizens has reiterated a "Market Perform" rating on HealthStream (NASDAQ: HSTM) before its third-quarter earnings report. The stock has seen a 63% surge in the past six months, trading near its 52-week high, although InvestingPro analysis suggests it is overvalued. HealthStream is set to release its Q3 results on November 2nd, with Citizens forecasting revenue of $82.5 million and EBITDA of $18.5 million.
HealthStream to Host Third Quarter 2026 Earnings Conference Call
HealthStream, Inc. (Nasdaq: HSTM) announced it will host a conference call and webcast on Tuesday, November 3, 2026, at 9:00 a.m. Eastern Time, to discuss its third quarter 2026 financial results. The results for the quarter ended September 30, 2026, will be released after market close on Monday, November 2, 2026. Participants can register in advance for telephone access or join via a webcast link.
HealthStream Rallies Into Q3 As Investment Ramp Tests Its Reaccelerating Growth Story
HealthStream is entering its Q3 report with a stock rally but a cautious outlook from management regarding slower growth and profitability due to increased spending. The report will test whether the market has accurately priced in both the past acceleration and the planned investment-driven pause. Investors will closely watch revenue growth, product mix performance, and remaining performance obligations to determine if the spending translates into sustainable long-term growth.
HealthStream (HSTM) Set to Announce Earnings on Monday
HealthStream (HSTM) is scheduled to release its Q3 2026 earnings after market close on Monday, November 2nd, with analysts expecting $0.1567 EPS on $82.24 million in revenue. The company surpassed expectations in the previous quarter, reporting $0.23 EPS and $83.73 million in revenue. Shares opened at $35.16, near their 52-week high, and the company maintains an average "Hold" rating from analysts with a $27.00 price target.
Form 144 HEALTHSTREAM INC For: 24 October By Investing.com
This article from Investing.com announces the filing of Form 144 for Healthstream Inc. on October 24, 2026. The brief notice provides the company's stock symbol, HSTM, and indicates a slight negative price performance of -0.30% at the time of publication. The content primarily serves as an alert for market participants interested in insider transaction filings.
Form 4 HealthStream Inc: Linda Rebrovick (Director) For: 23 October By Investing.com
This article reports on a Form 4 filing for HealthStream Inc, specifically noting a transaction by director Linda Rebrovick on October 23rd. The brief update, published by Investing.com, indicates the nature of the filing is standard for insider transaction disclosures. The article does not provide further details on the transaction itself.
Form 4 HealthStream Inc: Linda Rebrovick (Director) For: 23 October By Investing.com
This article reports a Form 4 filing for HealthStream Inc, detailing a transaction by Linda Rebrovick, a director of the company, for October 23. The filing is provided by Investing.com, a financial markets news and data platform. The article is brief, focusing solely on the announcement of the Form 4.
HealthStream, Inc. Estimates – NASDAQ:HSTM
This article provides access to financial actuals and analyst estimates for HealthStream, Inc. (NASDAQ: HSTM). Users can explore data across income statements, balance sheets, cash flow statements, and valuation metrics, comparing actual results with average, high, and low estimates, and visualizing trends over time. The platform explicitly states that the content is not investment advice and encourages users to conduct their own research.
HealthStream director Linda Rebrovick sells $420,000 in stock
Linda Rebrovick, a director at HealthStream Inc. (NASDAQ:HSTM), sold 12,000 shares of the company’s common stock for $420,000 on October 23, 2026, at a price of $35.00 per share. This sale, executed under a Rule 10b5-1 plan, occurred while the stock was near its 52-week high, with InvestingPro analysis suggesting it is overvalued. HealthStream recently reported strong Q2 2026 earnings, surpassing Wall Street expectations, and Freedom Capital initiated coverage with a "Hold" rating.
Insider Selling: HealthStream (NASDAQ:HSTM) Director Sells $420,000.00 in Stock
HealthStream Director Linda Rebrovick sold 12,000 shares of HSTM stock for $420,000 at an average price of $35.00, reducing her direct ownership by 23.38%. The transaction was executed under a Rule 10b5-1 trading plan, and comes as HealthStream's shares are trading near a one-year high. The company recently exceeded quarterly earnings and revenue estimates, while analysts maintain an overall "Hold" rating with an average price target of $27.
Director Linda Rebrovick proposes selling 12,000 HealthStream (NASDAQ: HSTM) shares.
HealthStream (NASDAQ: HSTM) director Linda Rebrovick has filed a Form 144 to propose the sale of 12,000 common shares, valued at an aggregate market value of $420,000. The proposed sale date is October 23, 2026, on Nasdaq, with UBS Financial Services, Inc. listed as the broker. The shares originate from various stock awards granted by HealthStream between 2016 and 2025.
HealthStream, Inc. Estimates – DUS:HL5
This page on TradingView provides financial estimates and actuals for HealthStream, Inc. (DUS:HL5), listed on the Dusseldorf Stock Exchange. Users can explore reported financial data and analyst estimates across income statements, balance sheets, cash flow statements, and valuation metrics, comparing actual results with various estimates and visualizing trends over time. The platform explicitly states that the information provided is not investment advice and encourages users to conduct their own research.
HealthStream stock hits 52-week high at $34.49
HealthStream (HSTM) stock reached a new 52-week high of $34.49, reflecting a 28.79% increase over the past year and a 56% surge in the last six months. This positive momentum follows strong Q2 2026 earnings, where the company exceeded analyst expectations for both profit and revenue, driven by subscription sales. Despite the stock's strong performance, InvestingPro analysis suggests it may be overvalued relative to its Fair Value.
HealthStream stock hits 52-week high at $34.49 By Investing.com
HealthStream Inc. (HSTM) has reached a new 52-week high of $34.49, reflecting a 28.79% increase over the past year and a 56% surge in the last six months. This positive momentum follows the company's impressive Q2 2026 earnings, which surpassed Wall Street expectations, and new coverage from Freedom Capital with a "Hold" rating and a $36.00 price target. Despite the stock's strong performance, InvestingPro analysis suggests it may be overvalued relative to its Fair Value.
Freedom Capital sets USD 36.00 target for HealthStream stock
Freedom Capital initiated coverage of HealthStream (HSTM) with a Hold rating and a USD 36.00 price target on October 13, 2026, citing accelerating growth and valuation. This target is higher than the consensus USD 27.00 average price target reported by MarketBeat. HealthStream reported strong second-quarter 2026 revenue of USD 83.73 million, exceeding estimates, but its 46.01 price-to-earnings ratio keeps valuation a key consideration for analysts.
HealthStream, Inc. (HSTM) Stock Forecasts
Argus has raised its target price for HealthStream, Inc. (HSTM) to $37.00. The company, which provides workforce and provider solutions for healthcare organizations, is currently priced at $33.13. This update comes from a quantitative report dated October 14, 2026.
Freedom Capital sets USD 36.00 target for HealthStream stock
Freedom Capital has initiated coverage on HealthStream (HSTM) with a Hold rating and a USD 36.00 price target. This target is 8.66 percent above the Nasdaq price of USD 33.13 recorded on October 16, 2026. HealthStream reported a 12.5 percent increase in second-quarter revenue year-over-year, reaching USD 83.73 million, with a market capitalization of USD 1.0 billion.